Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab)
Catalog No.
F1340
Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab)
Featured Products
Nivolumab is a humanized IgG4 antibody inhibitor of PD-1 used in the study of advanced (metastatic) non-small cell lung cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
145.24 kDa
Dry ice
946414-94-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BMS-936558, MDX-1106
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human PD-1 His at 2 ug/mL can bind Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab)
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.